{"id":"NCT01846442","sponsor":"EndoCeutics Inc.","briefTitle":"Topical DHEA Against Vaginal Atrophy","officialTitle":"Topical DHEA Against Vaginal Atrophy (3-Month Placebo-Controlled Double-Blind Randomized Phase III Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06","primaryCompletion":"2008-05","completion":"2008-10","firstPosted":"2013-05-03","resultsPosted":"2017-04-28","lastUpdate":"2017-08-29"},"enrollment":218,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Vaginal Atrophy"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":["Prasterone, Dehydroepiandrosterone"]},{"type":"DRUG","name":"DHEA (0.25%)","otherNames":["Prasterone, Dehydroepiandrosterone"]},{"type":"DRUG","name":"DHEA (0.5%)","otherNames":["Prasterone, Dehydroepiandrosterone"]},{"type":"DRUG","name":"DHEA (1.0%)","otherNames":["Prasterone, Dehydroepiandrosterone"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"0.25% DHEA","type":"EXPERIMENTAL"},{"label":"0.5% DHEA","type":"EXPERIMENTAL"},{"label":"1.0% DHEA","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the dose-response of vaginal mucosa parameters to the local action of DHEA (Dehydroepiandrosterone) in postmenopausal women suffering from vaginal atrophy.","primaryOutcome":{"measure":"Co-primary Endpoint: Change From Baseline to Week 12 of Vaginal Cell Maturation (Percentage of Parabasal Cells)","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"Placebo","deltaMin":46.7,"sd":8.64},{"arm":"0.25% DHEA","deltaMin":65.5,"sd":6.92},{"arm":"0.50% DHEA","deltaMin":53.4,"sd":7.49},{"arm":"1.00% DHEA","deltaMin":61.8,"sd":6.88}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":8,"countries":["United States","Canada"]},"refs":{"pmids":["19436226","19436225","19424093","20459349","21244215","24774442","25968836","25961226","26972555"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":54},"commonTop":["Headache","Nasopharyngitis","Vulvovaginal pruritus","Back pain","Vaginal discharge"]}}